Connecticut Convergence Institute CEO Dr. Cato Laurencin won a National Institutes of Health Pioneer Award for his exceptionally creative research in regenerative engineering. The $4 MM grant is part of the NIH’s program for high-risk research with potentially high rewards. The NIH Director’s Pioneer Award recognizes an exclusive class of individual scientists whose work is deemed exceptionally creative, highly innovative, and to have the potential to produce “unusually high impact” in addressing or solving “exceptionally important problems” in biomedical or behavioral sciences. Developing a new therapeutic strategy for the regeneration of complex musculoskeletal tissues and joints is proposed in Dr. Laurencin’s Pioneer Award. This work will revolutionize the way musculoskeletal tissue injury and wear is treated, tremendously improving the quality of lives of patients.
For more information about the NIH’s Pioneer Award, view the video below.